Active substanceLoperamideLoperamide
Similar drugsTo uncover
  • Vero-Loperamide
    pills inwards 
    VEROPHARM SA     Russia
  • Dyara
    pills inwards 
  • Diara®
    capsules inwards 
  • Imodium®
    pills inwards 
  • Imodium®
    capsules inwards 
  • Lopedium®
    capsules inwards 
    Sandoz d.     Slovenia
  • Lopedium®
    pills inwards 
    Sandoz d.     Slovenia
  • Loperamide
    capsules inwards 
    BIOKOM, CJSC     Russia
  • Loperamide
    pills inwards 
    PHARMACY 36.6, CJSC     Russia
  • Loperamide
    capsules inwards 
  • Loperamide
    pills inwards 
  • Loperamide
    pills inwards 
    BIOKOM, CJSC     Russia
  • Loperamide
    capsules inwards 
    NORTH STAR, CJSC     Russia
  • Loperamide
    pills inwards 
    OZONE, LLC     Russia
  • Loperamide
    pills inwards 
    LEKHIM-KHARKOV, CJSC     Ukraine
  • Loperamide Grindeks
    capsules inwards 
    GRINDEX, JSC     Latvia
  • Loperamide STADA
    capsules inwards 
    NIZHFARM, JSC     Russia
  • Loperamide-Akrihin
    capsules inwards 
    AKRIKHIN HFK, JSC     Russia
  • Sperilop
    capsules inwards 
  • Dosage form: & nbspcapsules
    Composition:

    1 capsule contains

    Active substance: loperamide hydrochloride 2.0 mg

    Excipients: lactose monohydrate (sugar milk) - 72.0 mg, potato starch - 25.0 mg, calcium stearate - 1.0 mg.

    Hard gelatin capsules №3: gelatin, titanium dioxide, iron oxide black, indigocarmine, iron oxide yellow.

    Description:

    Hard gelatin capsules number 3, the capsule body is gray, the lid capsule is green.

    The contents of capsules are white or almost white powder.

    Pharmacotherapeutic group:Antidiarrhoeic remedy
    ATX: & nbsp

    A.07.D.A   Drugs that reduce the peristalsis of the digestive tract

    A.07.D.A.03   Loperamide

    Pharmacodynamics:

    Loperamide, by binding to opioid receptors of the intestinal wall (stimulation of choline and adrenergic neurons via guanine nucleotides), reduces tone and mothoriku smooth muscles of the intestine, slows down the passage of the contents of the intestine, reduces the secretion of fluid and electrolytes with feces. Increases the tone of the anal sphincter, promotes retention of fecal masses and reduced urge to defecate. The action comes quickly and lasts 4-6 hours.

    Pharmacokinetics:

    Absorption - 40%. Time required to achieve maximum concentration (TCcmah) - 2.5 hours. The connection with plasma proteins is 97%. The half-life is 9-14 hours.Does not penetrate the blood-brain barrier. It is almost completely metabolized in the liver by conjugation. Excreted mainly by the intestine; a small part is excreted by the kidneys (in the form of conjugated metabolites).

    Indications:

    Symptomatic treatment of acute and chronic diarrhea of ​​various genesis (allergic, emotional, drug, radiation, with a change in diet and quality of food, in violation of metabolism and absorption, as an auxiliary for diarrhea of ​​infectious genesis). Regulation of stool in patients with ileostomy.

    Contraindications:

    Hypersensitivity to the drug, lactose intolerance, lactase deficiency or glucose-galactose malabsorption, diverticulosis, intestinal obstruction, ulcerative colitis in the acute stage, diarrhea on the background of acute pseudomembranous enterocolitis, in the form of monotherapy - dysentery and other infections of the gastrointestinal tract; pregnancy (I trimester), lactation period, loperamide capsules are not prescribed for children under 6 years.

    Carefully:

    Liver failure.

    Pregnancy and lactation:

    In the II and III trimesters of pregnancy Loperamide can be prescribed in cases where the expected benefit of therapy for the mother exceeds the potential risk to the fetus. Since a small amount of Loperamide is found in breast milk, taking it during breastfeeding is not recommended.

    Dosing and Administration:

    Inside, not liquid, squeezed water.

    Adults with acute and chronic diarrhea initially assigned 2 capsules (0.004 g), then 1 capsule (0.002 g) after each act of defecation in the case of a loose stool.

    In acute diarrhea, children over 6 years of age are prescribed 1 capsule (0.002 g) after each act of defecation in the case of a loose stool.

    The maximum daily dose. In acute and chronic diarrhea in adults - 8 capsules (0.016 g); in children - 3 capsules (0.006 g).

    After normalization of the stool or in the absence of stool for more than 12 hours, treatment with Loperamide should be discontinued.

    Side effects:

    Allergic reactions (skin rash), drowsiness or insomnia, dizziness, hypovolemia, electrolyte disorders; dryness of the mucous membrane of the cavity ppma, intestinal colic, gastralgia, pain or discomfort in the abdomen, nausea, vomiting, flatulence. Rarely - urinary retention, extremely rare - intestinal obstruction.

    Overdose:

    Symptoms: oppression of the central nervous system (stupor, impaired coordination, drowsiness, miosis, muscle hypertension, respiratory depression), intestinal obstruction.

    Treatment: antidote - naloxone; Considering that the duration of action of loperamide is greater than that of naloxone, it is possible to re-introduce the latter. Symptomatic treatment: Activated carbon, gastric lavage, artificial ventilation.

    Medical surveillance is necessary for at least 48 hours.

    Interaction:

    Not noted.

    Special instructions:

    If there is no effect after 2 days of Loperamide use, consult a doctor.

    If the treatment develop constipation or bloating, loperamide should be canceled.

    In patients with impaired liver function, careful monitoring of signs of toxic CNS damage is necessary.

    During the treatment of diarrhea, it is necessary to replenish the loss of fluid and electrolytes.

    Effect on the ability to drive transp. cf. and fur:

    During the treatment period, care must be taken when driving vehicles and engaging in other potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:Capsules 2 mg.
    Packaging:

    10 capsules per circuit cell packaging from film polyvinylchloride and aluminum foil. For 1, 2 contour squares are placed in a pack of cardboard along with instructions for use.

    Storage conditions:

    Store in a dry place, protected from light, out of reach of children, at a temperature not exceeding 25 ° C.

    Shelf life:

    2 years. Do not use at the expiration date indicated on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LS-000761
    Date of registration:02.11.2010
    Expiration Date:Unlimited
    The owner of the registration certificate:PRODUCTION OF MEDICINES, LTD. PRODUCTION OF MEDICINES, LTD. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp02.04.2018
    Illustrated instructions
      Instructions
      Up